Workshops
IPVC 2023 workshops will focus on this year’s theme, “Coming Together for HPV Elimination”. They will provide an overview to non-experts on all papillomavirus (PV)-related topics, from basic science to global health impact.
Workshops will be run by and have speakers who are worldwide leaders in the field. They will provide a unique forum for education and discussion.
At IPVC 2023, the workshops will be made up of two parts:
- The first day will start with two interdisciplinary workshops, consisting of a series of talks covering key aspects of basic science, clinical and public health, with plenty of opportunities for discussion and audience interaction.
- Thereafter, attendees will be able to join one of the three tracks – Basic Science, Clinical Science or Public Health, Epidemiology and Implementation Science – where specific topics of contemporary interest will be covered. A particular emphasis will be given to discussion on controversial areas of research and on experiences across different populations. In all sessions, audience interaction will be prioritized.
Although workshops stand alone as an educational and scientific activity, they are designed to provide the necessary scientific background to follow the main Conference, where the latest knowledge in research will be presented. For junior scientists, the workshops will help them to be educated on both the basics and cutting-edge knowledge of papillomavirus biology, epidemiology, and prevention and control of papillomavirus infection and disease.
IPVC 2023 workshops will be a unique way to connect across the fields, and attendees will enjoy PV research from different perspectives and participate in wider scientific discussions.
Monday, April 17, 2023
Click on the sections below to learn more about the workshops. Please note the information might be subject to change.
08:00 – 09:30 EDT (GMT -4)
Interdisciplinary Workshop 1: Epidemiology and Basic Science of HPV Infection and Related Diseases
Session Topic: Statistics on cervical cancer, Epidemiology of HPV infection, Experience of cancer patients, and Mechanisms of HPV carcinogenesis.
Session Description: Human papillomavirus (HPV) is sexually transmitted, and its persistent infection is causally associated with the development of cervical, vulvar, vaginal, anal, penile, and oropharyngeal cancers. This interdisciplinary session will review the latest global status of HPV-related cancers with real-life stories of cancer survivors, highlighting the urgency of cancer prevention and treatment. The basic mechanisms of cancer development due to HPV infection will also be presented to enhance understanding of clinical strategies for detecting and preventing HPV-associated cancers.
Learning Objectives:
- Listen to the real voices of cancer patients and understand the importance of HPV-related cancer control.
- Understand the current epidemiology of HPV infections and related diseases, including cervical, other anogenital, and head-and-neck cancers.
- Understand the basic molecular mechanisms of HPV-induced cancer development.
Chair: Suzanne Garland (Australia)
Chair: Toshiyuki Sasagawa (Japan)
Patient Experience (4 Pre-recorded Stories)
1) Cervix- Busisiwe Moyo (Zimbabwe)
2) Anal- Lillian Kreppel (USA)
3) Oropharynx – Julie McCrossin (Australia)
4) Penile- Patrick Howard (USA)
Global HPV-Driven Cancer: The Global Perspective
Silvia de Sanjosé (Spain)
The Epidemiology of HPV Infection
Talia Malagón (Canada)
Basic Mechanisms of HPV Carcinogenesis
John Doorbar (UK)
10:00 – 11:30 EDT (GMT -4)
Interdisciplinary Workshop 2: HPV Cancer Prevention: From Basic Science to Real-World Benefits
Session Topic: Immunology of HPV infection and vaccination, prevention of HPV-driven cancers via vaccination and screening including a focus on sexual and gender minorities.
Session Description: The success of the HPV vaccine is a prime example of the application of basic science achievements to clinical practice and public health interventions. The prophylactic vaccines comprising HPV L1 virus-like particles (VLPs) have shown remarkable efficacy against infection and disease caused by vaccine HPV types and are now beginning to have a real-world impact on cervical cancer incidence among vaccinated women. The high efficacy of the HPV vaccine is attributed to the long-lasting, anti-HPV antibody response induced by VLP vaccination. For many reasons, cervical cancer screening will remain a critical approach to controlling cervical cancer.
This session will present the latest understanding of HPV immunology and vaccinology, and summarize the current status and future of both HPV vaccination and cervical screening for eliminating cervical cancer. Additionally, how to prevent HPV-related cancers in sexual and gender minority populations (including but not limited to people who identify as lesbian, gay, bisexual, transgender, and non-binary) will be discussed.
Learning Objectives:
- Understanding cellular and humoral immunological responses induced by HPV natural infection and vaccination.
- Catch up on the current status of HPV vaccination and discuss future prospects.
- Catch up on the current status of cervical screening and discuss future prospects.
- Recognize the importance of expanding HPV prevention to minority groups.
Chair: Anna-Barbara Moscicki (USA)
Chair: John Doorbar (UK)
Basic Immunology of HPV Natural Infection and Vaccination
Denise Galloway (USA)
HPV Vaccination: Past, Present and Future
Joakim Dillner (Sweden)
Cervical Cancer Screening: Past, Present and Future
Rolando Herrero (Costa Rica)
HPV-Cancer Prevention In Sexual and Gender Minorities
Heather Brandt (USA)
Tuesday, April 18, 2023
Click on the sections below to learn more about the workshops. Please note the information might be subject to change.
Please note that the workshops for IPVC 2023 are included in the congress fee. No additional fee or pre-registration is required.